66.90
Ani Pharmaceuticals Inc Aktie (ANIP) Neueste Nachrichten
ANI Pharma stock drops on trial setback (ANIP:NASDAQ) - Seeking Alpha
ANI Pharmaceuticals Reports on NEW DAY Clinical Trial Results - TipRanks
ANI Pharmaceuticals reports mixed results from NEW DAY trial for DME - Investing.com
What analysts say about ANI Pharmaceuticals Inc. stockExplosive returns - jammulinksnews.com
ANI Pharmaceuticals Announces Results from NEW DAY Clinical - GlobeNewswire
Clinical Trial Reveals ILUVIEN Cuts DME Treatment Burden: Patients Need Only 2.8 vs 7.5 Injections - Stock Titan
What drives ANI Pharmaceuticals Inc. stock priceBreakthrough capital growth - jammulinksnews.com
Is ANI Pharmaceuticals Inc. a good long term investmentExponential return rates - jammulinksnews.com
ANI Pharmaceuticals Inc. Stock Analysis and ForecastFree Predictions - Autocar Professional
Analysts Offer Insights on Healthcare Companies: Gain Therapeutics (GANX), Abbott Laboratories (ABT) and ANI Pharmaceuticals (ANIP) - The Globe and Mail
Teacher Retirement System of Texas Has $303,000 Stock Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - Defense World
Healthcare Stocks to Watch: Gain Therapeutics, Abbott Laboratories, and ANI Pharmaceuticals - AInvest
Should I buy ANI Pharmaceuticals Inc. stock before earningsLow Risk Profit Ideas - Newser
How ANI Pharmaceuticals Inc. stock performs during market volatilityShort Term Risk Controlled Alerts - Newser
Why ANI Pharmaceuticals Inc. stock attracts strong analyst attentionLow Risk High Reward Picks - Newser
What makes ANI Pharmaceuticals Inc. stock price move sharplyReliable Low Risk Signals - Newser
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Average Recommendation of “Buy” from Analysts - Defense World
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Shares Bought by Principal Financial Group Inc. - Defense World
Brokers Offer Predictions for ANIP Q2 Earnings - Defense World
HC Wainwright Begins Coverage on ANI Pharmaceuticals (NASDAQ:ANIP) - Defense World
HC Wainwright Initiates ANI Pharmaceuticals at Buy With $84 Price Target - MarketScreener
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Position Boosted by Allspring Global Investments Holdings LLC - Defense World
GAMMA Investing LLC Has $95,000 Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - Defense World
Illinois Municipal Retirement Fund Has $546,000 Stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - Defense World
ANI Pharmaceuticals: Unlocking Rare Disease Growth Through Strategic Investor Engagement - AInvest
The Top 5 Analyst Questions From ANI Pharmaceuticals’s Q1 Earnings Call - Yahoo Finance
State of Alaska Department of Revenue Trims Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - Defense World
Raymond James Sticks to Its Buy Rating for ANI Pharmaceuticals (ANIP) - The Globe and Mail
ANI Pharmaceuticals Inc (ANIP) Shares Up 2.7% on Jun 18 - GuruFocus
ANI Pharmaceuticals (ANIP) Reveals New Preclinical Findings on Cortrophin Gel | ANIP Stock News - GuruFocus
ANI Pharmaceuticals Announces Presentation of New Preclinical Data - The Manila Times
Breakthrough Arthritis Treatment Data: Cortrophin Gel Successfully Reduces Joint Inflammation in Preclinical Study - Stock Titan
GAMMA Investing LLC Purchases 94,464 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 13,948 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - Defense World
ANI Pharmaceuticals (ANIP) Stock Price, News & Analysis - MarketBeat
ANI Pharmaceuticals at Jefferies Conference: Strategic Growth in Rare Diseases - Investing.com Canada
ANI Pharmaceuticals To Present At Jefferies Global Conference; Webcast At 2:35 PM ET - Nasdaq
ANI Pharmaceuticals Inc (ANIP) Shares Up 3.19% on Jun 2 - GuruFocus
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Shares Sold by Nuveen Asset Management LLC - Defense World
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):